Abstract
Understand the incidence, prevalence, etiology, and risk factors associated with erectile dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akpunona AZ, Mutgi AB, Federman DJ (1994) Routine prolactin measurement is not necessary in the initial evaluation of male impotence. J Gen Intern Med 9:336–338
Albaugh JA, Ferrans CE (2010) Impact of penile injections on men with erectile dysfunction after prostatectomy. Urol Nurs 30(1):64–77
Albaugh J, Amargo I, Capelson R, Flaherty E, Forest C, Goldstein I, Jensen PK, Jones K, Kloner R, Lewis J, Mullin S, Payton T, Rines B, Rosen R, Sadovsky R, Snow K, Vetrosky D, University of Medicine and Dentistry of New Jersey (2002) Health care clinicians in sexual health medicine: focus on erectile dysfunction. Urol Nurs 22(4):217–231; quiz 232
American Urological Association (2005) Management of erectile dysfunction, 3rd edn. Retrieved 15 Oct 2015, from http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=ed
Andersen I, Heitmann BL, Wagner G (2008) Obesity and sexual dysfunction in younger Danish men. J Sex Med 5(9):2053–2060. doi:10.1111/j.1743-6109.2008.00920.x
Androshchuk V, Pugh N, Wood A, Ossei-Gerning N (2015) Erectile dysfunction: a window to the heart. BMJ Case Rep. doi:10.1136/bcr-2015-210124
Annon JS (1974) The behavioral treatment of sexual problems, 1st edn. Kapiolani Health Services, Honolulu
Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60(4):458–465
Auxillium Pharmaceuticals Inc. (2011) Edex. Retrieved 2015, from http://www.edex.com/_assets/pdf/prescribing_information.pdf
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2003) Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139(3):161–168
Billups K, Friedrich S (2005) Assessment of fasting lipid panels and Doppler ultrasound testing in men presenting with erectile dysfunction and no other medical problem. Am J Cardiol 96(Suppl):57M–61M
Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2(1):40–50. doi:10.1111/j.1743-6109.2005.20104_1.x; discussion 50–52
Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA (2008) Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 20(3):236–242. doi:10.1038/sj.ijir.3901634
Blander DS, Sanchez-Ortiz RF, Wein AJ, Broderick GA (2000) Efficacy of sildenafil in erectile dysfunction after radical prostatectomy. Int J Impot Res 12(3):165–168
Boyle P (1999) Epidemiology of erectile dysfunction. In: Carson C, Kirby RS, Goldstein I (eds) Textbook of erectile dysfunction. ISIS Medical Media, Oxford, pp 15–29
Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH (2003) Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol 44(5):588–594
Cappelleri JC, Rosen RC (2005) The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17(4):307–319. doi:10.1038/sj.ijir.3901327
Carson C, McMahon C (2008) Fast facts: erectile dysfunction, 4th edn. Health Press, Ocford
Carson CC, Hatzichristou DG, Carrier S, Lording D, Lyngdorf P, Aliotta P, Auerbach S, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Patient Response with Vardenafil in Slidenafil Non-Responders Study Group (2004) Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. BJU Int 94(9):1301–1309. doi:10.1111/j.1464-410X.2004.05161.x
Carson CC, Kirby RS, Goldstein I, Wyllie MG (eds) (2009) Textbook of erectile dysfunction, 2nd edn. Informa Healthcare, New York
Cherry DK, Woodwell DA (2002) National ambulatory medical care survey: 2000 summary. Adv Data (328):1–32
Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP (2012) A review of outcomes of an intracavernosal injection therapy programme. BJU Int 110(11):1787–1791. doi:10.1111/j.1464-410X.2012.11080.x
Corona G, Mannucci E, Mansani R, Petrone L, Bartolini M, Giommi R, Forti G, Maggi M (2004) Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 46(2):222–228. doi:10.1016/j.eururo.2004.03.010
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB (2000) Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56(2):302–306
Eardley I (2013) The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 1(1):3–16. doi:10.1002/smrj.2
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, D’Armiento M, Giugliano D (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291(24):2978–2984. doi:10.1001/jama.291.24.2978
Federal Drug Administration (2007) FDA announces revisions to labels for Cialis, Levitra, and Viagra: potential risk of sudden hearing loss with ED drugs to be displayed more prominently. Retrieved 1 July 2015, from www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109012.htm
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151(1):54–61
Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metabol 87(2):589–598. doi:10.1210/jcem.87.2.8201
Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG (2010) Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 7(1 Pt 2):445–475. doi:10.1111/j.1743-6109.2009.01624.x
Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I (2006) The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med 166(2):213–219. doi:10.1001/archinte.166.2.213
Guay AT, Perez JB, Jacobson J, Newton RA (2001) Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 22(5):793–797
Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL (2011) The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 171(20):1797–1803. doi:10.1001/archinternmed.2011.440
Hatzichristou DG, Apostolidis A, Tzortzis V, Ioannides E, Yannakoyorgos K, Kalinderis A (2000) Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 164(4):1197–1200
Hatzimouratidis K, Hatzichristou D (2007) Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 51(1):75–88. doi:10.1016/j.eururo.2006.07.020; discussion 89
Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84(2):108–113. doi:10.4065/84.2.108
Jackson G, Rosen RC, Kloner RA, Kostis JB (2006) The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3(1):28–36. doi:10.1111/j.1743-6109.2005.00196.x; discussion 36
Jankowski JT, Seftel AD, Strohl KP (2008) Erectile dysfunction and sleep related disorders. J Urol 179(3):837–841. doi:10.1016/j.juro.2007.10.024
Jensen PK, Burnett JK (2002) Erectile dysfunction. Primary care treatment is appropriate and essential. Adv Nurse Pract 10(4):45–47, 51–52
Jensen PK, Lewis J, Jones KB (2004) Improving erectile function: incorporating new guidelines into clinical practice. Adv Nurse Pract 12(4):40–50
Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY (2002) Oxygen free radicals and the penis. Expert Opin Pharmacother 3(7):889–897
Kaplan SA, Gonzalez RR (2007) Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms. Rev Urol 9(2):73–77
Kendirici M, Bejma J, Hellstrom WJG (2006) Radical prostatectomy and other pelvic surgeries: effects on erectile function. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 135–154
Kinsey AC, Pomeroy WB, Martin CE (1948) Sexual behavior in the human male. W. B. Saunders, Philadelphia
Kloner RA, Speakman M (2002) Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 4(5):397–401
Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M (2007) A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 100(4):858–862. doi:10.1111/j.1464-410X.2007.07161.x
Kolodny RC, Kahn CB, Goldstein HH, Barnett DM (1974) Sexual dysfunction in diabetic men. Diabetes 23(4):306–309
Kuritzky L, Miner M (2004) Erectile dysfunction assessment and management in primary care practice. In: Broderick G (ed) Oral pharmacotherapy for male sexual dysfunction. Humana Press, Totowa, pp 149–183
LaRochelle JC, Levine L (2006) Evaluation of the patient with erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 253–270
Laumann EO, Paik A, Rosen RC (1999a) The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res 11(Suppl 1):S60–S64
Laumann EO, Paik A, Rosen RC (1999b) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281(6):537–544
Liu L, Zheng S, Han P, Wei Q (2011) Phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Urology 77(1):123–129. doi:10.1016/j.urology.2010.07.508
Lue TF (2000) Erectile dysfunction. N Engl J Med 342(24):1802–1813. doi:10.1056/NEJM200006153422407
Matsumoto AM (2002) Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57:M76–M99
Mazzola C, Mulhall JP (2011) Penile rehabilitation after prostate cancer treatment: outcomes and practical algorithm. Urol Clin N Am 38(2):105–118. doi:10.1016/j.ucl.2011.03.002
McCullough AR (2001) Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 28(3):613–627
McCullough AR (2003) The penis as a barometer of endothelial health. Rev Urol 5(Suppl 7):S3–S8
McCullough AR (2008) Rehabilitation of erectile function following radical prostatectomy. Asian J Androl 10(1):61–74. doi:10.1111/j.1745-7262.2008.00366.x
McMahon CG (2004) Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 1:292–300
Meda Pharmaceuticals Inc. (2014) MUSE full prescribing information. Retrieved 23 Oct 2016, from http://www.muserx.com/hcp/global/full-prescribing-information.aspx
Montague DK, Jarrow JP, Broderick GA, Dmochoski RR, Heaton JP, Lue TF, Milbank AJ, Nehra A, Sharlip ID (2005) Erectile dysfunction guideline update panel: the management of erectile dysfunction. J Urol 174(1):230–239
Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 158(4):1408–1410
Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, Guazzoni G, Losa A, Rigatti P, Pizzini G (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 56(6):906–911
Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C (2008) Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54(4):924–931. doi:10.1016/j.eururo.2008.06.083
Mulhall JP (2008) Penile rehabilitation following radical prostatectomy. Curr Opin Urol 18(6):613–620. doi:10.1097/MOU.0b013e3283136462
Mulhall J, Land S, Parker M, Waters WB, Flanigan RC (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2(4):532–540. doi:10.1111/j.1743-6109.2005.00081_1.x; discussion 540–542
Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G (2010) Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 7(4 Pt 2):1687–1698. doi:10.1111/j.1743-6109.2010.01804.x
Mydlo JH, Viterbo R, Crispen P (2005) Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy. BJU Int 95(6):843–846. doi:10.1111/j.1464-410X.2005.05413.x
Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC (2012) The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 87(8):766–778. doi:10.1016/j.mayocp.2012.06.015
NIH Consensus Panel on Impotence (1993) Impotence. NIH Consensus Development Panel on Impotence. JAMA 270(1):83–90
Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, Giuliano F, Brock G, Study Group (2008) Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 20(5):479–486. doi:10.1038/ijir.2008.33
Pahlajani G, Raina R, Jones S, Ali M, Zippe C (2012) Vacuum erection devices revisited: its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy. J Sex Med 9(4):1182–1189. doi:10.1111/j.1743-6109.2010.01881.x
Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ (2013) Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int 112(6):844–851. doi:10.1111/bju.12253
Porst H, Giuliano F, Glina S, Ralph D, Casabe AR, Elion-Mboussa A, Shen W, Whitaker JS (2006) Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 50(2):351–359. doi:10.1016/j.eururo.2006.02.052
Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, Hellstrom W, Martin-Morales A, Salonia A, Sharlip I, ISSM Standards Committee for Sexual Medicine (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10(1):130–171. doi:10.1111/jsm.12023
Pritzker MR (1999) The penile stress test: a window to the hearts of man? Circ J 100(Suppl 1):3751
Rabbani F, Schiff J, Piecuch M, Yunis LH, Eastham JA, Scardino PT, Mulhall JP (2010) Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years? J Sex Med 7(12):3984–3990. doi:10.1111/j.1743-6109.2010.01969.x
Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD (2005) Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 65(2):360–364. doi:10.1016/j.urology.2004.09.013
Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, Mansour D, Zippe CD (2006) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 18(1):77–81. doi:10.1038/sj.ijir.3901380
Raina R, Pahlajani G, Agarwal A, Zippe CD (2008) Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience. Int J Impot Res 20(2):121–126. doi:10.1038/sj.ijir.3901573
Rhoden EL, Ribeiro EP, Teloken C, Souto CA (2005) Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int 96(6):867–870. doi:10.1111/j.1464-410X.2005.05728.x
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44(6):637–649
Rowland DL, Incrocci L, Slob AK (2005) Aging and sexual response in the laboratory in patients with erectile dysfunction. J Sex Marital Ther 31(5):399–407. doi:10.1080/00926230591006520
Sachs BD (2003) The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. Int J Impot Res 15(1):72–78. doi:10.1038/sj.ijir.3900952
Sadovsky R, Curtis K (2006) How a primary care clinician approaches erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 77–104
Seftel AD, Sundi P, Swindle R (2004) The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 171:2341–2345
Selvin E, Burnett AL, Platz EA (2007) Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120(2):151–157. doi:10.1016/j.amjmed.2006.06.010
Sesti C, Florio V, Johnson EG, Kloner RA (2007) The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res 19:55–61
Shabsigh R (2006) Epidemiology of erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 47–59
Shamloul R, Ghanem H (2013) Erectile dysfunction. Lancet 381(9861):153–165. doi:10.1016/S0140-6736(12)60520-0
Stember DS, Mulhall JP (2012) The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy 11(2):87–96. doi:10.1016/j.brachy.2012.01.002
Tal R, Teloken P, Mulhall JP (2011) Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members. J Sex Med 8(8):2370–2376. doi:10.1111/j.1743-6109.2011.02355.x
Teloken PE, Smith EB, Lodowsky C, Freedom T, Mulhall JP (2006) Defining association between sleep apnea syndrome and erectile dysfunction. Urology 67(5):1033–1037. doi:10.1016/j.urology.2005.11.040
Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y, EAU (2006) EAU Guidelines on erectile dysfunction: an update. Eur Urol 49(5):806–815. doi:10.1016/j.eururo.2006.01.028
Zias N, Bezwada V, Gilman S, Chroneou A (2009) Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor? Sleep Breath 13(1):3–10. doi:10.1007/s11325-008-0212-8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Sexual Health Inventory for Men (SHIM)
Sexual Health Inventory for Men (SHIM)
Patient Instructions
Sexual health is an important part of an individual’s overall physical and emotional well-being. Erectile dysfunction, also known as impotence, is one type of a very common medical condition affecting sexual health. Fortunately, there are many different treatment options for erectile dysfunction. This questionnaire is designed to help you and your provider identify if you may be experiencing erectile dysfunction.
Each question has several possible responses. Circle the number of the response that best describes your own situation. Please be sure that you select one and only one response for each question.
Over the Past 6 Months
-
1.
How do you rate your confidence that you could get and keep an erection?
1
2
3
4
5
Very low
Low
Moderate
High
Very high
-
2.
When you had erections with sexual stimulation, how often were they hard enough for penetration?
0
1
2
3
4
5
No sexual activity
Almost never/never
A few times
Sometimes
Most times
Almost always/always
-
3.
During sexual intercourse, how often were you able to maintain an erection after penetration?
0
1
2
3
4
5
Did not attempt
Almost never/never
A few times
Sometimes
Most times
Almost always/always
-
4.
How difficult was it to maintain your erection to the completion of intercourse?
0
1
2
3
4
5
Did not attempt
Extremely difficult
Very difficult
Difficult
Slightly difficult
Not difficult
-
5.
How often was sexual intercourse satisfactory to you?
0
1
2
3
4
5
Did not attempt
Almost never/never
A few times
Sometimes
Most times
Almost always/always
Total Score: __________
Scoring Key:
22–25: No ED | 12–16: Mild-to-moderate ED | 1–7: Severe ED |
17–21: Mild ED | 8–11: Moderate ED |
Used with permission from Rosen et al. (1999).
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jensen, P.K., Albaugh, J.A. (2016). Erectile Dysfunction: Identification, Assessment, Treatment, and Follow-Up. In: Lajiness, M., Quallich, S. (eds) The Nurse Practitioner in Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-28743-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-28743-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28741-6
Online ISBN: 978-3-319-28743-0
eBook Packages: MedicineMedicine (R0)